Tilray Brands (TLRY) Accounts Payables (2017 - 2026)
Tilray Brands (TLRY) reported Accounts Payables of $115.3 million for Q1 2026, down 46.74% on a YoY basis from $216.6 million in Q1 2025, and up 0.73% quarter-over-quarter from $114.5 million in Q4 2025.
Tilray Brands (TLRY) Accounts Payables (2017 - 2026) Analysis & Trends
Tilray Brands has reported Accounts Payables for 10 years, with the latest figure at $115.3 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 46.74% year-over-year to $115.3 million; the trailing twelve-month figure through Feb 2026 stood at $115.3 million (down 46.74% YoY), and the FY2025 full-year result was $107.3 million, down 55.63% from the prior year.
- Accounts Payables for Q1 2026 stood at $115.3 million, up from $114.5 million in the prior quarter.
- The five-year high for Accounts Payables was $242.0 million in Q2 2024, with the low at $67.1 million in Q1 2023.
- Historically, Accounts Payables has averaged $150.8 million across 5 years, with a median of $137.1 million in 2022.
- Annual changes were most pronounced in 2024 — Accounts Payables jumped 241.66% — and 2025, when it tumbled 55.63%.
- Tilray Brands' Accounts Payables stood at $75.7 million in 2022, then rose by 16.69% to $88.4 million in 2023, then soared by 150.86% to $221.7 million in 2024, then slumped by 48.35% to $114.5 million in 2025, then advanced by 0.73% to $115.3 million in 2026.
- The last three Accounts Payables figures came in at $115.3 million (Q1 2026), $114.5 million (Q4 2025), and $230.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 115.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 115.33 Mn |
| Nov 30, 2025 | 114.50 Mn |
| Aug 31, 2025 | 230.91 Mn |
| May 31, 2025 | 107.35 Mn |
| Feb 28, 2025 | 216.57 Mn |
| Nov 30, 2024 | 221.67 Mn |
| Aug 31, 2024 | 236.15 Mn |
| May 31, 2024 | 241.96 Mn |
| Feb 29, 2024 | 90.16 Mn |
| Nov 30, 2023 | 88.36 Mn |
| Aug 31, 2023 | 238.08 Mn |
| May 31, 2023 | 70.82 Mn |
| Feb 28, 2023 | 67.07 Mn |
| Nov 30, 2022 | 75.73 Mn |
| Aug 31, 2022 | 154.66 Mn |
| May 31, 2022 | 157.43 Mn |
| Feb 28, 2022 | 137.09 Mn |
| Nov 30, 2021 | 168.30 Mn |
| Aug 31, 2021 | 190.21 Mn |
| May 31, 2021 | 212.81 Mn |